sorry, never trusted the guy. He has his nose all the way up JL's rear for years and now he does not like JL. I have been against him for years, still not a fan, but it seems like ARNA has a pipeline, so maybe if JL just steps aside and lets a drug development pro assume responsibility, ARNA will be successful. Maybe JL is a visionary, but not a good commercial leader and not business savvy. ARNA needs someone with Wall Street smarts to lead and that's not Jack or the Bean Counter.
Has ARNA picked a new Chair? I could not find one listed on the web site. In the absence of a new chair, JL might as well still be the chair. They need to elect someone that's not an insider/friend to JL and the other execs.
Interesting, according to the web site JL served as the Chairman of our Board of Directors from October 2007 to December 2014. There was no notice of his change from Chairman? Who is the Chairman? The BOD members have all been around for 7-8+ years, they need some new blood.
Who is this Belcher clown, ran a printing company? Great pick!
At least Bice a prof was on the BOD of Jenny Craig. New talent is needed!
say what? Who is the new chair, his son, or nephew, or best friend? I was hoping he would drop the CEO post and take the Chair role. One small step for shareholders.
1) Kevin Conroy, the company's chairman and chief executive, will make Exact's presentation at the Baird Growth Stock Conference in Chicago at 10:55 a.m. CT on Wednesday, May 6.
2) Mr. Conroy will make the company's presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas at 4:20 p.m. PT on Tuesday, May 12.
3) Bill Megan, the company's senior vice president of finance, will make Exact's presentation at the UBS Global Healthcare Conference in New York at 4 p.m. ET on Tuesday, May 19.
yes, it will take some serious institutional buying or an acquisition to beat these bio-short HF criminals into submission. While I would love an exit at a reasonable price, I keep wondering what MEDX would be worth if they had stayed public a little longer. BMS stole them in hindsight; the whole BMS immunotherapy drug platform and pipeline came from that acquisition. Is ARNA another MEDX? It's possible.
ARNA has upside potential of at least 3-4X in the next 12-24 months if just 1-2 things go well in their pipeline and the shorts are forced to cover. That would be nice!
They have to try and sell more naked shares to stop the price rise, their borrowing costs are going to increase, ARNA needs a knock out blow to really get the price flying. if JL and co would just buy some stock on the open market, ARNA would fly. Stop selling and start buying JL, or cisit with the ARIA CEO in forced retirement.
Today they took one small step in that direction. This is good news, no let's get that S1P1 drug going and catch up to Receptos in market cap!
Teva what, are we speculating? I guess Teva is as good as any. Just pay me $8+ and I'm out. My price keeps going lower. Any opportunity to BK the shorts if good for me.
$42K or 42K shares? Many of us own more than $42K of this POS stock, I mean future winner. The only way this goes to $8 is in a buy-out and that's not happening until/unless Eisai releases ARNA from the Bel deal and we get more clinical info/progress. I don't think it will be this week.
ARNA, $144MM in projected profits, R U smoking something S9? I think many would be happy with $144MM in revs in 2018. Also, I believe VVUS has a ton of cash (and debt). I agree they (VVUS) are going to zero, but the lenders will get their drug and sell it to a generic firm. How about some good science, or pipeline development news from ARNA???
wow, thanks for the info, this is great! Should I buy a new car now, or wait for the stock to double? If we could get a triple, I could quit my job, at least for a year. Go ARNA! Go Jack! Go Team! OK, back to reality now, this POS never goes up!
add IMGN to the list, the only good things they developed, they gave away to Roche T-DM1 and Sanofi (naked antibody still in development). I doubt they will amount to anything. ARNA still has a chance, but I'm still not a Jack fan as the leader going forward.